These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 22943680)

  • 41. USAFAM cardiovascular disease followup study: comparisons of serum lipid and lipoprotein levels.
    Clark DA; Allen MF; Wilson FH
    Aerosp Med; 1974 Oct; 45(10):1167-70. PubMed ID: 4429057
    [No Abstract]   [Full Text] [Related]  

  • 42. [Deficits in lipid lowering therapy and achieving target lipid concentrations in patients with high risk of a cardiovascular event].
    Petrus J; Málek F; Dvořák J; Mates M; Kmoníček P; Skalníková V; Neužil P
    Vnitr Lek; 2012 Jun; 58(6):430-3. PubMed ID: 22913234
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antihypertensives: much ado about lipids.
    Golomb BA; Criqui MH
    Arch Intern Med; 1999 Mar; 159(6):535-7. PubMed ID: 10090108
    [No Abstract]   [Full Text] [Related]  

  • 44. Management of lipids in the elderly.
    Winder A
    J R Soc Med; 1998 Apr; 91(4):189-91. PubMed ID: 9659303
    [No Abstract]   [Full Text] [Related]  

  • 45. [Chinese expert consensus on lipid management of very high-risk atherosclerotic cardiovascular disease patients].
    ;
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Apr; 48(4):280-286. PubMed ID: 32370478
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lipids and cardiovascular disease.
    Burnett JR; Hooper AJ; Hegele RA
    Pathology; 2019 Feb; 51(2):129-130. PubMed ID: 30595506
    [No Abstract]   [Full Text] [Related]  

  • 47. Building scientific consensus: the importance of dietary fiber.
    Schneeman BO
    Am J Clin Nutr; 1999 Jan; 69(1):1. PubMed ID: 9925113
    [No Abstract]   [Full Text] [Related]  

  • 48. Review of lipids, cardiovascular disease, and oral contraceptives.
    Corson SL
    Fertil Steril; 1990 Aug; 54(2):363-4. PubMed ID: 2379639
    [No Abstract]   [Full Text] [Related]  

  • 49. [Chinese expert consensus for assessment of cardiovascular risk in asymptomatic adults].
    ;
    Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Oct; 41(10):820-4. PubMed ID: 24377885
    [No Abstract]   [Full Text] [Related]  

  • 50. A step forward in the consensus on lipid profile characteristics for cardiovascular prevention.
    Pintó X; Pedro-Botet J
    Clin Investig Arterioscler; 2023; 35(2):85-87. PubMed ID: 37076207
    [No Abstract]   [Full Text] [Related]  

  • 51. Lipids.
    Brewer HB
    Am J Cardiol; 1995 Feb; 75(6):43B-44B. PubMed ID: 7863973
    [No Abstract]   [Full Text] [Related]  

  • 52. Therapy and clinical trials.
    Cramb R
    Curr Opin Lipidol; 2003 Feb; 14(1):111-3. PubMed ID: 12544668
    [No Abstract]   [Full Text] [Related]  

  • 53. [Chinese expert consensus of psychological prescription for patients in cardiovascular department].
    ;
    Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Jan; 42(1):6-12. PubMed ID: 24680259
    [No Abstract]   [Full Text] [Related]  

  • 54. [Residual vascular risk: recommendations of the Spanish Initiative for the Reduction of Residual Risk].
    Núñez-Cortés JM; Pedro-Botet Montoya J; Pintó Sala X;
    Med Clin (Barc); 2010 Jul; 135(4):165-71. PubMed ID: 20434183
    [No Abstract]   [Full Text] [Related]  

  • 55. [Iron and residual vascular risk lipid profile dependent: a forgotten relationship].
    Del Castillo-Rueda A; Alvarez-Sala Walther LA
    Med Clin (Barc); 2011 Jun; 137(2):91-2. PubMed ID: 21145084
    [No Abstract]   [Full Text] [Related]  

  • 56. Heaven can wait… for lipid control in very high cardiovascular risk patients.
    Mello E Silva A
    Rev Port Cardiol (Engl Ed); 2021 Sep; 40(9):649-651. PubMed ID: 34503702
    [No Abstract]   [Full Text] [Related]  

  • 57. [Emerging risk factors related to residual risk].
    Millán J; Pedro-Botet J; Pintó X;
    Med Clin (Barc); 2011 Jun; 137(2):92-3. PubMed ID: 21145077
    [No Abstract]   [Full Text] [Related]  

  • 58. Correlation between atherogenic index of plasma and coronary artery disease in males of different ages: a retrospective study.
    Hong L; Han Y; Deng C; Chen A
    BMC Cardiovasc Disord; 2022 Oct; 22(1):440. PubMed ID: 36210443
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Atherogenic index of plasma is an effective index for estimating abdominal obesity.
    Shen SW; Lu Y; Li F; Yang CJ; Feng YB; Li HW; Yao WF; Shen ZH
    Lipids Health Dis; 2018 Jan; 17(1):11. PubMed ID: 29334966
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Chinese expert consensus on blood lipid related cardiovascular residual risk control].
    ;
    Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Jul; 40(7):547-53. PubMed ID: 22943680
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.